Accessibility Menu
 
Idexx Laboratories logo

Idexx Laboratories

(NASDAQ) IDXX

Current Price$562.49
Market Cap$45.07B
Since IPO (1991)+59,929%
5 Year+3%
1 Year+20%
1 Month+1%

Idexx Laboratories Financials at a Glance

Market Cap

$45.07B

Revenue (TTM)

$4.30B

Net Income (TTM)

$1.06B

EPS (TTM)

$13.08

P/E Ratio

43.38

Dividend

$0.00

Beta (Volatility)

1.18 (Average)

Price

$562.49

Volume

37,541

Open

$568.37

Previous Close

$562.49

Daily Range

$554.07 - $568.37

52-Week Range

$465.00 - $769.98

IDXX: Motley Fool Moneyball Superscore

83

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Idexx Laboratories

Industry

Healthcare Equipment and Supplies

Employees

11,000

CEO

Jonathan J. Mazelsky, MBA

Headquarters

Westbrook, ME 04092, US

IDXX Financials

Key Financial Metrics (TTM)

Gross Margin

62%

Operating Margin

32%

Net Income Margin

25%

Return on Equity

66%

Return on Capital

62%

Return on Assets

32%

Earnings Yield

2.31%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$45.07B

Shares Outstanding

79.42M

Volume

37.54K

Avg. Volume

537.88K

Financials (TTM)

Gross Profit

$2.66B

Operating Income

$1.36B

EBITDA

$1.47B

Operating Cash Flow

$1.18B

Capital Expenditure

$124.68M

Free Cash Flow

$1.05B

Cash & ST Invst.

$180.07M

Total Debt

$1.08B

Idexx Laboratories Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$1.09B

+14.3%

Gross Profit

$658.11M

+15.3%

Gross Margin

60.35%

N/A

Market Cap

$45.07B

N/A

Market Cap/Employee

$4.10M

N/A

Employees

11,000

N/A

Net Income

$248.19M

+14.8%

EBITDA

$356.22M

+19.3%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$897.14M

-28.4%

Accounts Receivable

$693.19M

+23.5%

Inventory

$377.76M

-1.1%

Long Term Debt

$577.14M

+5.4%

Short Term Debt

$500.07M

+13.8%

Return on Assets

31.62%

N/A

Return on Invested Capital

61.76%

N/A

Free Cash Flow

$322.59M

+44.8%

Operating Cash Flow

$352.02M

+34.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CAHCardinal Health, Inc.
$197.06+0.93%
ZTSZoetis Inc.
$112.68-1.30%
EWEdwards Lifesciences Corporation
$83.33-0.77%
ARGXargenx SE
$811.09+3.52%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$13.14-0.01%
CNSPCns Pharmaceuticals
$7.84+2.39%
GBTGGlobal Business Travel Group
$9.34+0.58%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.18+0.01%

Questions About IDXX

What is the current price of Idexx Laboratories?

Idexx Laboratories is trading at $562.49 per share.

What is the 52-week range for Idexx Laboratories?

Over the past 52 weeks, Idexx Laboratories has traded between $465.00 and $769.98.

How much debt does Idexx Laboratories have?

As of the most recent reporting period, Idexx Laboratories reported total debt of $976.06M.

How much cash does Idexx Laboratories have on hand?

Idexx Laboratories reported $180.07M in cash and cash equivalents in its most recent financial results.

What is Idexx Laboratories’s dividend yield?

Idexx Laboratories does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.